About Radionetics
Radionetics is a company based in San Diego (United States) founded in 2021 by R Scott Struther.. Radionetics has raised $136.71 million across 4 funding rounds from investors including Crinetics, Frazier Healthcare Partners and Frazier Life Sciences. Radionetics offers products and services including Small Molecule Radiopharmaceuticals and Diagnostic Radiopharmaceuticals. Radionetics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter San Diego, United States
- Founders R Scott Struther
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$136.71 M (USD)
in 4 rounds
-
Latest Funding Round
$52.5 M (USD), Series A
Jan 03, 2024
-
Investors
Crinetics
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Radionetics
Radionetics offers a comprehensive portfolio of products and services, including Small Molecule Radiopharmaceuticals and Diagnostic Radiopharmaceuticals. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers targeted radiation to tumors via GPCRs for treatment
Maps tumors using radioisotopes for precise patient identification
Unlock access to complete
Funding Insights of Radionetics
Radionetics has successfully raised a total of $136.71M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $52.5 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $52.5M
-
First Round
First Round
(28 Oct 2021)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series A - Radionetics | Valuation | Frazier Life Sciences , 5AM Ventures | |
| Oct, 2023 | Amount | Series A - Radionetics | Valuation | GordonMD Global Investments |
|
| Aug, 2023 | Amount | Series A - Radionetics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Radionetics
Radionetics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Crinetics, Frazier Healthcare Partners and Frazier Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investment firm focused on novel therapeutics development.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Radionetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Radionetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Radionetics Comparisons
Competitors of Radionetics
Radionetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Radionetics
Frequently Asked Questions about Radionetics
When was Radionetics founded?
Radionetics was founded in 2021.
Where is Radionetics located?
Radionetics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Radionetics a funded company?
Radionetics is a funded company, having raised a total of $136.71M across 4 funding rounds to date. The company's 1st funding round was a Series A of $54.21M, raised on Oct 28, 2021.
What does Radionetics do?
Radionetics was founded in 2021 in San Diego, United States, within the biotechnology sector. Peptide-targeted radiotherapeutics are developed by the company, which bind to receptors overexpressed on tumors. These treatments are focused on neuroendocrine tumors and advanced prostate cancer. Operations center on advancing targeted therapies for oncology applications in the radiopharmaceutical field.
Who are the top competitors of Radionetics?
Radionetics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Radionetics offer?
Radionetics offers Small Molecule Radiopharmaceuticals and Diagnostic Radiopharmaceuticals.
Who are Radionetics's investors?
Radionetics has 6 investors. Key investors include Crinetics, Frazier Healthcare Partners, Frazier Life Sciences, 5AM Ventures, and DCVC.